LUCD|EPS -$0.10|Rev $1.5M|Net Loss $16.3MLucid Diagnostics Inc. (LUCD) posted Q4 2025 adjusted EPS of -$0.10. The company generated $1.5M in revenue for the quarter. Revenue of $1.5M was up 25.6% year-over-year.
Lucid Diagnostics Inc. is a Medical Devices company. EsoGuard revenue was 2 millions for the quarter. The company operated 3,664 EsoGuard tests processed at quarter end. Bottom line showed a net loss of $16.3M.
Wall Street consensus stands at 11 buy, 1 hold, 0 sell. Year-over-year, EPS moved up 50.0% from the -$0.20 posted in Q4 2024. That represents a 25.6% increase from the $1.2M recorded in Q4 2024.
This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.